Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Guangxi Wuzhou Zhongheng Group Co Ltd

600252:SHH

Guangxi Wuzhou Zhongheng Group Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)2.85
  • Today's Change0.26 / 10.04%
  • Shares traded303.60m
  • 1 Year change+6.34%
  • Beta0.8027
Data delayed at least 15 minutes, as of Nov 01 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

GUANGXI WUZHOU ZHONGHENG GROUP CO., LTD is a China-based company, principally engaged in the manufacture of pharmaceuticals and food production. The Company's pharmaceuticals include cardiovascular drugs, medicine for bruises, gynecology medication and other general drugs. The Company also provides Chinese herbal jelly products, Chinese herbal beverages and others. The Company is also engaged in the development of real estate, including the development and sales of commercial housings and stores. The Company mainly conducts its businesses within domestic market and to overseas markets.

  • Revenue in CNY (TTM)2.86bn
  • Net income in CNY-24.94m
  • Incorporated1993
  • Employees2.89k
  • Location
    Guangxi Wuzhou Zhongheng Group Co LtdNo. 1Industrial Avenue, Industrial ParkWUZHOU 543000ChinaCHN
  • Phone+86 7 743939022
  • Fax+86 7 743939053
  • Websitehttps://www.wz-zhongheng.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shenzhen Chipscreen Biosciences Co Ltd656.24m-70.33m9.12bn1.06k--5.55--13.89-0.1709-0.17091.604.030.20222.344.47620,847.90-2.171.32-2.441.5486.2493.29-10.726.972.76-0.55840.4410.00-1.1828.81408.0923.3110.23--
Nanjing Vazyme Biotech Co Ltd1.40bn23.59m9.13bn2.70k370.882.29--6.510.06150.06153.849.970.26441.063.57519,483.100.412213.160.523715.9270.2170.501.5623.924.17--0.143632.20-63.9749.74-111.94--48.61--
GuangYuYuan Chinese Herbal Medicn Co Ltd1.24bn136.56m9.32bn1.81k68.255.95--7.520.2790.2792.533.200.50110.56472.60684,557.406.04-2.108.71-3.1672.2169.7412.05-6.000.987321.000.0267--13.56-4.53136.03-24.78-58.35--
Cansino Biologics Inc748.53m-720.11m9.57bn1.49k--2.67--12.78-2.92-2.923.0320.460.08510.63411.12501,023.80-8.41-4.27-11.09-5.5967.7141.73-98.82-27.602.27-8.750.2934---65.49163.48-63.04--30.60--
North China Pharmaceutical Co Ltd9.71bn79.38m9.69bn10.16k121.431.81--0.99880.04650.04655.683.130.44922.674.34955,385.000.6731-0.29781.54-0.704229.7935.731.50-0.59850.56091.640.6482---3.621.89100.71-49.624.22-19.73
Guangxi Wuzhou Zhongheng Group Co Ltd2.86bn-24.94m9.84bn2.89k--1.51--3.44-0.0074-0.00740.83791.890.24762.174.52990,180.10-0.31382.26-0.48363.3842.3372.05-1.277.272.39--0.176745.6714.10-1.266.69-32.76-4.56-30.12
Harbin Pharmaceutical Group Co., Ltd.16.22bn613.05m9.92bn9.85k16.291.90--0.61180.24180.24186.382.071.156.293.471,646,115.004.780.741412.561.8927.6023.874.150.72941.1136.800.36330.0011.937.41-14.882.69-5.38--
Zhejiang Hisun Pharmaceutical Co., Ltd.9.55bn-34.96m10.06bn8.06k--1.22--1.05-0.0412-0.04128.206.830.5553.234.281,184,162.00-0.34671.95-0.56633.7739.0840.58-0.62483.430.6491--0.369626.07-13.820.3618-119.05---31.58--
Youcare Pharmaceutical Group Co Ltd3.95bn96.27m10.12bn3.18k105.162.80--2.560.21380.21388.768.040.67132.214.431,241,400.001.657.112.4811.6557.1564.142.458.071.404,818.810.197760.95-7.611.05-44.84-7.1623.40--
Changchun BCHT Biotechnology Co1.61bn414.29m10.53bn1.24k25.422.51--6.551.001.003.8810.150.31811.001.061,295,333.008.209.9510.2312.8187.5586.6325.7724.031.85--0.014710.5570.3012.36175.9831.3721.04--
Jiangsu Sinopep Allsin Bphrmctcl Co Ltd1.58bn421.47m10.64bn1.55k25.704.07--6.751.881.887.1411.910.42861.193.671,020,281.0011.585.8616.997.5967.1255.4127.0117.200.91224.020.347727.5958.6932.2426.2029.9927.32--
Data as of Nov 01 2024. Currency figures normalised to Guangxi Wuzhou Zhongheng Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

5.49%Per cent of shares held by top holders
HolderShares% Held
China Investment Corp. (Investment Management)as of 08 Mar 202449.78m1.45%
China Southern Asset Management Co., Ltd.as of 08 Mar 202425.30m0.74%
Da Cheng Fund Management Co., Ltd.as of 08 Mar 202425.30m0.74%
GF Fund Management Co., Ltd.as of 08 Mar 202425.28m0.74%
Yinhua Fund Management Co., Ltd.as of 08 Mar 202421.27m0.62%
China Universal Asset Management Co., Ltd.as of 30 Jun 202412.13m0.35%
The Vanguard Group, Inc.as of 30 Sep 20249.72m0.28%
China Asset Management Co., Ltd.as of 30 Jun 20247.31m0.21%
Wanjia Asset Management Co., Ltd.as of 30 Jun 20246.98m0.20%
Fullgoal Fund Management Co., Ltd.as of 30 Jun 20245.60m0.16%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.